Posted by Michael Wonder on 24 Mar 2020
New restrictions on prescribing hydroxychloroquine for COVID-19
24 March 2020 - In recent days there has been considerable focus on the potential for hydroxychloroquine and the similar compound chloroquine (which is not marketed in Australia) to help in treating COVID-19.
Hydroxychloroquine is used for treatment of malaria and certain autoimmune diseases.
Recent reports of increased off-label prescribing of medicines containing hydroxychloroquine have raised concerns that this will create a potential shortage of this product in Australia.
